Genitourinary Cancer
Feature
ASCO says ‘no’ to home infusions of cancer treatment, with exceptions
The American Society of Clinical Oncology has warned against intravenous infusion of chemotherapy and monoclonal antibodies in cancer patients’...
From the Journals
OK to treat many cancer patients despite pandemic, says ESMO
ESMO recommends against stopping or delaying cancer treatment that can impact survival.
Conference Coverage
Better continence rate gives robotic prostatectomy the edge
A large trial confirms early continence is better with a robotic rather than classical laparoscopic approach.
Conference Coverage
Higher death rate seen in cancer patients with nosocomial COVID-19
All-cause mortality was higher in cancer patients with hospital-acquired COVID-19 than in those with community-acquired COVID-19.
Conference Coverage
Robotic renal surgery bests open partial nephrectomy
Fewer complications were seen during and after surgery when partial nephrectomy was performed using robotic assistance versus an open procedure....
Conference Coverage
CCC19, other registries help define COVID-19/cancer landscape
New data from CCC19 show an increased risk of death from COVID-19 among non-Hispanic black cancer patients and patients with hematologic...
From the Journals
Genetic differences by ancestry shouldn’t impact efficacy of prostate cancer therapies
There were no significant differences in clinically actionable DNA repair genes, microsatellite instability-high status, or tumor mutation burden...
Conference Coverage
Intravesical BCG dosing frequency ‘critical’ in bladder cancer
Reducing the dosing frequency of bacillus Calmette-Guérin more than doubled the rate of disease recurrence.
Conference Coverage
PSMA PET/CT may be new ‘gold standard’ for prostate cancer staging
PSMA PET/CT was 27% more accurate than conventional imaging for detecting metastases and staging men with high-risk prostate cancer.
Feature
Cancer patient organizations critically affected by COVID-19
Conference Coverage
MRI reliably identifies significant prostate cancer